SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-151020
Filing Date
2023-05-23
Accepted
2023-05-23 06:09:53
Documents
15
Period of Report
2023-05-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d451263d8k.htm   iXBRL 8-K 30340
2 EX-5.1 d451263dex51.htm EX-5.1 11608
3 EX-10.1 d451263dex101.htm EX-10.1 148242
7 GRAPHIC g451263g0523065207399.jpg GRAPHIC 1826
  Complete submission text file 0001193125-23-151020.txt   367557

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA icvx-20230522.xsd EX-101.SCH 2841
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE icvx-20230522_lab.xml EX-101.LAB 18737
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE icvx-20230522_pre.xml EX-101.PRE 11701
9 EXTRACTED XBRL INSTANCE DOCUMENT d451263d8k_htm.xml XML 3458
Mailing Address 1930 BOREN AVE., SUITE 1000 SEATTLE WA 98101
Business Address 1930 BOREN AVE., SUITE 1000 SEATTLE WA 98101 (206) 737-0085
Icosavax, Inc. (Filer) CIK: 0001786255 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40655 | Film No.: 23946455
SIC: 2836 Biological Products, (No Diagnostic Substances)